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Abstract
Reproduction, an energetically costly process, is subject to nutritional and metabolic
control. There is a high occurrence of female infertility in obese women, and Polycystic Ovarian
Syndrome (PCOS), a condition characterized by androgen excess and oligo- and amenorrhea, is
highly associated with obesity and diabetes mellitus. Obesity is characterized by chronic, lowgrade inflammation and increased circulating pro-inflammatory cytokines. These proinflammatory molecules can alter insulin signaling, thereby contributing to glucose intolerance
and insulin resistance, both hallmarks of type 2 diabetes. This study seeks to elucidate the
relationship between obesity, inflammation, and reproductive dysfunction through diet
intervention. Diets rich in n-3 poly-unsaturated fatty acids (PUFAs), such as found in fish oil,
are considered to have anti-inflammatory effects. We induced obesity and reproductive
dysfunction in C57BL/6 female mice by feeding a “Western-type” high fat diet (45% energy
from fat) with lard as the source of fat. At 16 weeks of age, the experimental group was switched
to a diet of identical composition but with fish oil as a source of fat for an additional 8 weeks.
Changes in reproductive function and estrous cycle regularity were assessed by vaginal cytology.
Metabolic outcomes were evaluated by measuring body weight, food consumption, glucose
tolerance, fasting insulin levels, and adipose and liver histology. Inflammatory status was
determined by circulating cytokine and adipokine levels. Reproductive irregularity was
successfully established by 16 weeks of age at which time the mice also had increased glucose
intolerance and higher circulating leptin levels. At 24 weeks, mice that had remained on the lard
based diet weighed more, had a dramatic increase in fat deposition in the liver, showed worse
glucose tolerance response, and had higher fasting insulin levels than their fish-oil counterparts.
Consumption of the fish oil diet for 8 weeks did not restore estrous cycle regularity for all
C57BL/6 female mice, however, cyclicity did improve for fish oil mice that exhibited reduced
iii

weight gain. These findings suggest including fish oil in the diet of obese females will improve
metabolic status and improve estrous cycle regularity for those whose weight is responsive to the
treatment.
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Introduction
Background
Between 2003 and 2004, 33.2% of adult women in the US were obese. With nearly one
third of the female adult population (and a comparable 32.2% of all US adults) having this
condition, obesity is justifiably one of the United States’ primary public health concerns (Ogden
CL et al.). The etiology of this epidemic cannot be narrowed to one specific cause, but is a
consequence of a complex relationship between genetics, environment, lifestyle, and diet. The
health complications associated with obesity are abundant: insulin resistance, cardiovascular
disease, dyslipidemia, inflammation (Buettner, Schölmerich, and Bollheimer), and there are also
other physiological effects downstream of these more direct metabolic consequences. One such
system that responds to energetic signals is the reproductive system. Reproduction in female
mammals, from ovulation to weaning, is an energetically costly process. It therefore should come
as no surprise that reproduction is metabolically controlled, and that metabolic dysfunction as
induced during obesity, plays a role in the disruption of normal reproductive function. This
project seeks to elucidate the relationship between obesity induced by a high-fat diet, obesityinduced inflammation, and reproductive dysfunction (by way of estrous cycle regularity) using
C57Bl/J6 mice as a model.
High-fat Diets and Obesity
High-fat diets (containing more than 30% energy as fat) have successfully been used to
generate models of obesity in laboratory animals since as early as the 1940s. Such models have
been able to recreate the conditions associated with human obesity: weight gain, insulin
resistance and type II diabetes, dyslipidemia, increase in adipocyte number and size, high blood
pressure, and high leptin and low adiponectin levels. However, this is only consistently true for
1

HFD models that use lard or ω-6/ω-9-containg plant oils as the primary fat source, whereas diets
that use fish oil (ω-3 poly-unsaturated fatty acids) as a fat source are protective against the
weight gain and insulin resistance (Buettner, Schölmerich, and Bollheimer).
Obesity and Inflammation
Obesity is characterized by chronic low-grade inflammation, which is the body’s
protective response to infection or cellular injury. The inflammatory response begins with the
body’s recognition of injury or foreign pathogen, to which it responds with the release of
cytokines (small proteins that serve as signaling molecules) that recruit phagocytic cells to the
site of injury. These phagocytic cells contain the insult as well as recruit additional immune cells.
Such a response is trigged by foreign pathogen or, in the case of obesity, sterile activation. Other
examples of sterile inflammatory activators include mechanical trauma, environmental irritants,
and ischemia (Lukens, Gross, and Kanneganti). During the development of obesity, there is an
increase in the visceral adipose tissue depot and adipocyte hypertrophy that leads to the
production of pro-inflammatory mediators such as tumor necrosis factor-α (TNFα), and
interleukon-6 (IL-6). Hypertrophic adipocytes also allow for the infiltration of activated
macrophages into adipose tissue, which in turn contributes to increased plasma levels of TNFα
and IL-6 (Kanda et al.). One mechanism for the development of insulin resistance itself is
thought to be caused by the changes in levels of these inflammatory mediators, as TNFα and IL6 lead to the interruption of insulin signaling by inhibiting insulin receptor (IR) tyrosine kinase
activity (Dandona, Aljada, and Bandyopadhyay; Hotamisligil et al.). Additionally, it has been
found that high amounts of saturated free fatty acids (FFAs), but not unsaturated fatty acids, can
activate Toll-like receptors and directly activate pro-inflammatory cytokine synthesis (Lee et al.,
2001).
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The adipocyte-derived hormones leptin and adiponectin also influence the chronic proinflammatory state in obesity. Leptin, known as the satiety hormone, belongs to the cytokine
class I receptor family and acts on the hypothalamic nuclei to reduce food intake and promote
energy expenditure (Otero et al.; Meier and Gressner). Although complete leptin deficiency
results in an obese phenotype, obese individuals exhibit higher levels of serum leptin than their
normal-weight counterparts. In fact, circulating serum leptin levels are positively correlated with
amount of body fat, suggesting that obese individuals are insensitive to leptin’s effects (i.e.,
leptin insensitive), which may be due to defects in leptin’s signal transduction pathway
(Considine et al.; Myers, Cowley, and Münzberg). Leptin has been shown to promote
phagocytosis and the production of pro-inflammatory cytokines (Loffreda et al.). Adiponectin, a
protein also secreted by adipocytes, decreases insulin resistance and blood glucose levels. In
obesity and type II diabetes, circulating adiponectin levels are low compared to metabolically
normal individuals. Unlike leptin, adiponectin exerts an anti-inflammatory effect by negatively
regulating C-reactive protein (CRP), which activates the complement system and TNFα
expression in adipose tissues. TNFα and IL-6, however, inhibit the expression of adiponectin
(Meier and Gressner; Ouchi and Walsh).
Various immune populations have been implicated in the obese-inflammatory state.
Regulatory T cells, also known as Tregs, suppress the immune responses of other cells and are
integral in the maintenance of immune homeostasis and self-tolerance. As reviewed in Chen et
al., there are a number of associations between Tregs, obesity, and insulin resistance. Tregs
accumulate in the visceral adipose tissue of normal, lean mice but not in that of obese mice, and
a reduction in Tregs in obese animal models is closely associated with insulin resistance and
adipose inflammation. Additionally, adoptive transfer of visceral adipose Tregs into obese mice
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was shown to significantly improve insulin sensitivity and glucose tolerance, while deletion of
the same population was associated with a substantial decrease of insulin sensitivity and increase
in inflammatory mediators (Chen, Wu, and Wang). A more recent study proposed a possible
mechanism for this Treg regulation, showing that hyperinsulinemia reduces the ability of Tregs
to produce the anti-inflammatory cytokine interleukin-10 (IL-10) as well as their ability to
suppress the production of TNFα. (Han et al.).
In addition to Tregs, another population of immune cells has been linked to obesityinduced inflammation and insulin resistance: Gr-1+ CD11b+ myeloid-derived suppressor cells
(MDSCs). These cells also cause immune suppression following inflammatory injury by
inhibiting the activation of cytotoxic T cells, reducing natural killer (NK) cell cytotoxicity,
promoting the proliferation of Tregs, and skewing macrophage polarization toward M2
macrophages (as opposed to M1 or “angry” macrophages) (Xia et al.; Ostrand-Rosenberg et al.).
In high fat feeding animal models, Gr-1+ CD11b+ MDSCs are highly expressed in adipose tissue
and the liver in early stages of obesity. Ablation of this population in obese mice resulted in
significantly increased inflammation, insulin resistance, and glucose intolerance, while adoptive
transfer of this population into obese animal models improved glucose tolerance (Xia et al.).
As previously mentioned, high-fat diets containing primarily ω-3 poly-unsaturated fatty
acids (PUFAs) as a fat source do not induce the same metabolic effects as Western-type diets,
which are rich in saturated and monounsaturated fats, and particularly important for this study,
ω-6 polyunsaturated fatty acids. This is, in part, due to the systemic inflammation-reducing
effects of ω-3 PUFAs, which act to reduce the proportion of arachidonic acid in immune cell
membranes thereby reducing the synthesis of pro-inflammatory mediators. Additionally, diets
high in ω-3 PUFAs result in increased fatty oxidation and thereby reduced adiposity (and thus
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reduced infiltration of adipose tissue by macrophages) and yield higher levels of adiponectin
compared with Western-type high-fat diets (Calder).
Reproduction and energetics
The obesity epidemic has prompted researchers to more closely examine the relationship
between metabolism and other physiological functions—one of these functions being
reproduction. Frisch and Macarthur originally proposed in 1974 that a critical level of stored
energy is necessary for the onset and maintenance of reproductive function. This also implies
that a female who falls below this critical energy storage, even when reproductive maturity has
been reached, will cease to menstruate. Although this theory has been seriously challenged in the
years following its proposal, there is some merit to the idea that energy status and reproduction
are linked. While the process of ovulation itself may not necessarily be energetically costly,
ovulation incurs the risk of pregnancy, lactation, and parenting, which, as any parent will agree,
are energetically costly processes. Ovulation status then should reflect an animal’s overall energy
status, such that much needed energy for survival is not wasted on attempts at reproduction,
which in times of starvation or chronic negative energy balance, would likely be unsuccessful
(Bronson and Manning). Indeed, a negative overall energy balance is associated with disruption
of normal menstruation, as seen in the amenorrhea of women diagnosed with anorexia nervosa.
Upon return to a normal body weight, many women with anorexia nervosa resume menses
(American Psychiatric Association; Falk and Halmi). Cessation of normal cycling during times
of chronic starvation (normal rat food intake was reduced by 50%) has also been observed in
laboratory animal models as shown by Knuth and Friesen.. By as early as the third expected
cycle, anestrus was observed in a significant number of rats.
The disruption of normal ovulation and cycling in times of negative energy status is well
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established, but less intuitive is this disruption during periods of chronic energy excess (i.e.,
obesity). It would seem that consistent positive energy balance would mean consistent
reproductive success, as excess energy stored in adipose tissue would be more than sufficient for
reproductive (and overall) energy demands if mobilized to oxidizable free fatty acids (FFAs).
Wade and Schneider proposed that in obese individuals, the body is primed for storage rather
than mobilization and oxidation of metabolic fuels, resulting in an effective shortage of energy
(Wade and Schneider). This predisposition toward storage would result in reproductive
impairment similar to those seen in chronic undernutrition. Support for this appeared in 1952
even before this explanation was proposed when Rogers and Mitchell reported that obesity is
associated with amenorrhea in women. In 1974, Hartz et al. showed that with increasing severity
of obesity, there is increasing incidence of anovulatory cycles and irregular menstruation. Similar
effects have been observed in laboratory animals, including estrous cycle irregularities in overfed
rats, fewer overall cycles in high-fat diet induced obese mice, and total sterility of the morbidly
obese ob/ob (leptin-deficient) mouse (Glick et al.; Sharma et al.; Ewart-Toland et al.). Similarly,
metabolic syndrome and Type 1 Diabetes are also associated with disruption in normal
reproductive function, further exemplifying the relationship between metabolism and
reproduction (Codner, Merino, and Tena-Sempere; Brothers et al.).
Mechanisms underlying obesity related reproductive dysfunction
If metabolism and reproduction are so highly intertwined, what is the actual link between
the two? The hypothalamic-pituitary-gonadal (HPG) axis controls reproduction in humans and
other mammals through regulating many endocrine organs. The activation of this axis results in
menstruation and cycling and it therefore must be sensitive to metabolic signals.
The regulation of reproduction and the estrous cycle occurs mainly through the
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neurosecretory molecule gonadotropin releasing hormone (GnRH), released from the
hypothalamus, which acts on the anterior pituitary to stimulate the synthesis and secretion of the
gonadotropins leutenizing hormone (LH) and follicle stimulating hormone (FSH). LH and FSH
in turn, target the ovaries and uterus in females, stimulating the production of the sex steroids
estrogen, progesterone, and testosterone—all of which contribute to the development and
maintenance of the genital tract. The sex steroid estradiol functions on this axis in two ways: 1)
at low levels, it exerts negative feedback control over FSH and LH and 2) at prolonged, high
levels, induces LH and FSH surge. The steroid progesterone enhances the negative feedback
effects and blocks the positive feedback effects of estradiol (Johnson; Goldman, Murr, and
Cooper). The relationship between these steroids and gonadotropins throughout the phases of the
rodent estrous cycle are reviewed in Goldman et al.’s 2007 paper “The Rodent Estrous Cycle:
Characterization of Vaginal Cytology and its Utility in Toxilogical Studies” and Johnson’s text
Essential Reproduction (Goldman, Murr, Cooper; Johnson). The normal rodent estrous cycle
lasts approximately 4-5 days and occurs in 4 phases: proestrus, estrus, metestrus, and diestrus.
Proestrus and estrus are characterized by epithelial growth in the reproductive tract, with estrus
culminating in ovulation. Metestrus is characterized by degenerative epithelial changes, and
diestrus is characterized by quiescence and slow cell growth (Quimby).
The hypothalamus, and more specifically the arcuate nucleus, also serves as an important
site of regulation for energy intake and expenditure in the body. It is the site of action for the
adipocyte-derived hormone leptin, which is thought to be the best candidate for the link between
reproduction and metabolism. Leptin, as previously mentioned, is the product of the ob gene and
suppresses food intake and stimulates energy expenditure. Kennedy and Mitra first showed that
both the reproductive axis and leptin signaling occur in the hypothalamus (Kennedy and Mitra).
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The leptin-deficient homozygous recessive ob/ob mouse, first produced by Jackson Laboratory in
1949, exhibited not only morbid obesity and type II diabetes, but also total sterility and low
levels of LH suggesting that leptin plays an important role somewhere along the reproductive
axis (Ingalls, Dickie, and Snell; Zhang et al.). Supplementation with exogenous leptin can restore
fertility in both male and female ob/ob mice (Chehab et al.). Later studies showed that
administration of even low concentrations of leptin in vivo were able to stimulate the release of
LH via both hypothalamic and pituitary action (Yu et al.).
Polycystic ovarian syndrome
In humans, one of the main manifestations of reproductive dysfunction associated with
obesity is polycystic ovarian syndrome (PCOS). PCOS is characterized by oligoovulation or
anovulation, androgen excess, and sometimes, but not always, polycystic ovaries. In women with
PCOS, LH release is increased compared to FSH release, which contributes to increased
androgen production. Women diagnosed with PCOS often are obese (sources citing anywhere
from 16-80%) and insulin resistant, suggesting that insulin resistance is a major factor in driving
the condition. Increased androgen production has been found to drive insulin resistance, but it is
thought that genetic predispositions to improper insulin receptor signaling in conjunction with
obesity are the main driving factors of the androgen excess and reproductive abnormalities
(Dunaif). It has yet to be fully explored how the obese state exacerbates this condition, but the
recent findings linking inflammation to insulin resistance implicate obesity-induced
inflammation could play a significant role in further driving PCOS.
Although the genetic predispositions to PCOS are not present in laboratory animals,
reproductive dysfunction is still seen in obese animals, and thus laboratory animals prone to dietinduced obesity can serve as a model for probing the etiology of the condition. Our hypothesis is
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that changes in immune populations and inflammatory mediators associated with insulin
resistance will precede insulin resistance. We expect that once insulin resistance is established,
reproductive dysfunction by way of irregular cycling will follow.
Study Aims
This first aim of this study is to confirm that inflammation-mediated metabolic and
reproductive dysfunction can be established through feeding C57Bl/6 mice a high-fat Westerntype diet high in n-6 fatty acids. The second aim of this study is to see if substituting the source
of fat with one that is rich in n-3 polyunsaturated fatty acids will result in improved metabolic
and reproductive outcomes due to its anti-inflammatory nature.
Materials and Methods
Animals and diets
C57BL/6 female mice were bred and housed at the University of Memphis campus.
(Breeding pairs purchased from Harlan Laboratories, Inc., Indanapolis, IN). All animals received
food and water ad libitum under a 12-hour dark/12-hour light cycle. To establish our model,
female mice were weaned at 3 weeks of age onto a standard rodent chow diet (Chow, n=13) or a
Western-type diet (HFL, n=13) composed of 45% energy from fat (45% kcal from lard-based fat,
41% carbohydrate, 20% sucrose, 9% cornstarch, 12% Maltodextrin 10) and were exposed to
their respective diets until 20 weeks of age. For our intervention, female mice (n=18) were
weaned onto the HFL diet through 16 weeks age, at which point half of the mice (n=9) were
converted to a high-fat diet of 45% kcal which substituted Menhaden (fish) oil (HFO) as the fat
source while the other half (n=8) remained on HFL until sacrifice at 24 weeks of age (Table 1A).
Mice were group housed with no more than 5 mice per cage. Food intake and total body weight
were measured twice per week. The high-fat experimental diets were identical in overall
9

composition but differed in their fatty acid profiles (Table 1B). The HFL diet contained a higher
ω -6 to ω -3 fatty acid ratio than the HFO diet (13.1 to 0.3 respectively). The HFL diet contained
high amounts of stearic, oleic, and linoleic acid while the HFO diet contained greater amounts of
stearidonic, eicosapentaenoic (EPA), docosapentaenoic, and docosahexaenoic acid (Table 1B).
All experiments were conducted in accordance with the National Institutes of Health Guidelines
for the Care and Use of Experimental animals and were approved by the University of Memphis
Institutional Animal Care and Use Committee.
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Table 1. Composition of Experimental Diets. HFL n-6 with 45% kcals/g from lard; HFO n-3
with 45% kcals/g from menhaden oil. (A) ingredients in HFL-n-6 and HFO n-3 diets; (B) fatty
acid composition of HFL n-6 and HFO n-3 diets.
A
Ingredients
Protein
Carboyhydrate
Fat
Total
kcal/g
Casein, 80 Mesh
L-Cystine
Sucrose
Corn Starch
Maltodextrin 10
Cellulose, BW200
Soybean Oil
Lard
Menhaden Oil (200 ppm tBHQ)
tBHQ
Mineral Mix S10026
Vitamin Mix V10001
Choline Bitartrate
Cholesterol
*BHQ: tert-Butylhydroquinone

HFL n-6
gm (%)
24
41
24

kcal (%)
20
35
45
100

4.72

HFO n-3
gm (%)
24
41
24

kcal (%)
20
35
45
100

4.72

200
3
172.8
72.8
100.0
50
25
177.5
0
0.0355
10
10
2
0.58

800
12
691
291
400
0
225
1598
0
0
0
40
0
0
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200
3
172.8
72.8
100.0
50
25
0
177.5
0
10
10
2
0

800
12
691
291
400
0
225
0
1598
0
0
40
0
0

Table 1. Composition of Experimental Diets. HFL n-6 with 45% kcals/g from lard; HFO n-3
with 45% kcals/g from menhaden oil. (A) ingredients in HFL-n-6 and HFO n-3 diets; (B) fatty
acid composition of HFL n-6 and HFO n-3 diets.
B
Ingredients (g)
Lard
Menhaden Oil, ARBP-F
Soybean Oil
Total
C14, Myristic
C16:1, Palmitoleic
C18, Stearic
C18:2, Linoleic
C18:3, Linolenic, n3
C18:4, Stearidonic, n3
C20, Arachidic
C20:4, Arachidonic, n6
C20:4, n3
C22:5, Docosapentaenoic, n3
C22:5, n6
C22:6, Docosahexaenoic, n3
Total
Saturated (g)
Saturated (%)
Monounsaturated (g)
Monounsaturated (%)
Polyunsaturated (g)
Polyunsaturated (%)
ω-6 (g)
ω-3 (g)
ω-6/ω-3 ratio

HFL n-6
177.5
0
25
202.5
2.1
2.5
19.8
56.2
4.2
0
0.4
0.5
0
0.2
0
0
190.7
60.2
31.6
67.7
35.5
62.8
32.9
57.0
4.4
13.1
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HFO n-3
0
177.5
25
202.5
14.0
17.7
6.6
16.1
4.3
6.0
0.3
0
3.1
4.1
0.6
29.0
189.6
59.8
31.5
41.3
21.8
88.5
46.7
17.9
66.6
0.3

Tissue collection and histology
Tissues were harvested and weighed at sacrifice for each animal. A portion of liver,
adipose tissue, and ovaries were fixed in formalin solution (Fisher Scientific Co. LLC),
embedded in paraffin, and 4um sections were stained with hemotoxylin and eosin. Adipocyte
size (average surface area of 10-15 randomly selected adipocytes from each mouse were
determined using Axiovision r4.8.2 software. Analysis and documentation were performed using
an imager M2 microscope (Axiocam MRC, Zeiss, Oberkochen, Germany). A second portion of
liver, adipose tissue, and ovaries were snap-frozen in liquid nitrogen and stored at -80˚C for
cytokine and adipokine analysis. The spleen, mesenteric lymph nodes (MLNs), and the
remainder of liver and adipose tissue were collected and immediately processed for immune cell
population analysis. Spleens and MLNs were placed into RPMI 1640 solution containing 2%
FBS. Liver was placed into MACS buffer containing 2% FBS. Adipose tissue was placed in to
DMEM (HyClone, GE Healthcare Life Sciences, Logan, Utah).
Glucose tolerance test and fasting insulin measurement
At 8, 12, 16, 20, and 24 weeks of age, half of the mice were subjected to a glucose
tolerance test (GTT). Mice were fasted for 6 hours and a baseline fasting blood glucose level was
measured from a tail vein sample using a glucometer (Onetouch Ultra 2 Meter, Bayer
Healthcare, Tarrytown, New York). Mice then received an intraperitoneal injection of glucose (2
g/kg body weight), and blood glucose readings were measured again at 30, 60, and 90 minutes
after the injection. For fasting insulin measurements, the mice that did not undergo GTT were
fasted for 6 hours, and serum samples were collected from the cheek vein and stored at -80˚C
and subsequently analyzed by ELISA (Thermo Fisher Scientific, Waltham, MA).
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Cytokine and adipokine analysis
Plasma samples were collected from the cheek vein of mice and stored at -80˚C. Lysates
were made from previously snap-frozen tissue samples by lysing and homogenizing in the
presence of a protease inhibitor (Thermo Fisher Scientific) and centrifuged at 15000 RPM for 10
minutes. Plasma and tissue cytokine and adipokine levels were measured via magnetic bead
assay (R&D Systems, Minneapolis, MN) and read on the Luminex MAGPIX platform.
Measurement of Estrous Cycle Regularity
Vaginal lavage was performed on mice to determine estrous cyclicity. To establish our
model, the mice that remained on a single diet for 20 weeks were evaluated for 14 days starting
at 16 weeks of age. To test intervention effects, mice weaned onto high-fat lard were evaluated
for 14 days at 14 weeks of age until their intervention (16 weeks of age). These mice were then
evaluated again for 14 days beginning at week 22 until sacrifice. Lavage fluid was placed onto
slides and allowed to dry. Smears were stained with methylene blue and classified as proestrus,
estrus, metestrus, or diestrus based on the proportion of nucleated epithelial cells, cornified
epithelial cells, and leukocytes present.
Cell suspensions
Livers, spleens and MLNs were isolated by mashing with the end of a syringe plunger
and filtered through a 40 µm nylon mesh filter. Spleens and whole blood was treated with red
blood cell lysis buffer. Spleens, MLNs, and blood were spun at 1700 RPM for 7 minutes and
resuspended in PBS containing 2% FBS. Liver cells were diluted into 8ml of MACS buffer
containing 2% FBS, overlayed onto 3 ml of Lympholyte cell separation media (Cedarlane,
Burlington, NC) and centrifuged without brakes for 25 minutes at 2250 RPM. The buffy coat
above the lympholyte was removed and diluted into 15 ml PBS with 2% FBS and centrifuged at
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1700 RPM for 7 minutes and resuspended in PBS with 2% FBS. Adipose tissue was minced and
treated with 2 mg/ml type II collagenase (Worthington, Lakewood, New Jersey) in DMEM
incubated and shook for 40 minutes at 37˚C and filtered through a 40 µm nylon mesh filter. Cells
were then centrifuged at 500 G for 10 minutes and resuspended in PBS with 2% FBS.
Flow cytometry
Cells were counted using a Neubauer improved hemocytometer and plated onto a 96
well-plate such that each well contained between 1 and 5 million cells. Cells were centrifuged at
1500 RPM for 5 minutes, the supernatant was removed. Cells were then incubated with fragment
crystallizable block (FcX, Biolegend, San Diego, California) diluted in PBS with 2% FBS (1:50)
on a plate shaker in the dark at room temperature for 10 minutes to prevent nonspecific antibody
binding. Cells were then incubated with population specific antibodies at optimum
concentrations (Table 2) for 30 minutes on a plate shaker in the dark at room temperature. Cells
were spun at 1500 RPM for 5 minutes, the supernatant was removed, and the cells were
suspended in fixative solution (eBioscience, San Diego, California) overnight at 4˚C. In the
morning, fixative was removed by centrifuging at 1500 RPM for 5 minutes, and supernatant was
discarded. Cells receiving intracellular stains were incubated with Fc block diluted in
permeabilization buffer (eBioscience, San Diego, California) for 15 minutes at room temperature
on a plate shaker in the dark. Cells were then incubated with the intracellular antibody diluted in
permeabilization buffer for 30 minutes at room temperature on a plate shaker in the dark. Cells
were centrifuged once more at 1500 RPM for 5 minutes, supernatant was discarded, and cells
were resuspended in PBS with 2% FBS for analysis using the LSR II Flow Cytometer (BD
Biosciences, San Jose, California).
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Table 2. Antibodies used for flow cytometric analysis
Marker

Clone

Concentration

Conjugate

Source

B220

RA3-6B2

1:100

APC/Cy7

BioLegend

CD3

145-2C11

1:100

PE/Cy7

BioLegend

CD4

GK1.5

1:100

APC

BioLegend

CD8

53-6.7

1:100

APC/Cy7

BioLegend

CD11b

M1/70

1:100

APC

BioLegend

CD11c

N418

1:100

PE/Cy7

BioLegend

Foxp3

FJK-165

1:100

PE

eBioscience

1:200

Life
Technologies
BioLegend

LDA
Ly6c

HK1.4

1:100

Pacific
Orange
FITC

Ly6g

1A8

1:100

PE

BioLegend

Vβ7

TR310

1:100

FITC

BioLegend

Statistics
Data are presented as means ± SEM. Statistical significance between different
experimental groups was determined using the non-parametric Mann-Whitney U test due to
small n values. p-values less than 0.05 were considered statistically significant.
Results
A diet rich in ω-6 fatty acids induces obesity, glucose intolerance, and liver damage
Mice exposed to the HFL diet containing 45% kcal from lard gained more weight than
their chow fed counterparts (Figure 1). Significant differences in total weight were observed by 9
weeks of age, and at sacrifice HFL mice weighed on average 50.8% more than chow mice.
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Figure 1. Time course for body weight gain. Mice were fed a chow (n=12) or HFL (n=13) diet
and total body weight measured weekly from weaning until 20 weeks of age.). HFL mice gained
more weight over time than chow mice. Results represent mean ± SEM (Chow SEMs included
not visible . * p<0.05

Chow mice consumed more food by weight over the study period (Figure 2), but gained less
weight per gram of food consumed (Figure 3), consistent with the HFL diet being more energy
dense The HFL diet contained 45% fat and has a energy value of 4.72 kcal/g, while the chow diet
contains only 6% fat and has an energy value of 3.2 kcal/g.
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Figure 2. Total amount food consumed per mouse. Food consumption was measured twice
weekly for each cage of mice. Total food consumption per mouse (Chow, n=8; HFL, n=13) was
obtained by summing food intake over the study period and dividing by the number of mice in
the cage. Chow mice consumed more food by weight than HFL mice. Results represent mean ±
SEM. *p<.0001

Figure 3. Weight gained per kcal of food consumed. Change in each mouse’s weight from
weaning until sacrifice was divided by total amount of food consumed per mouse for that
mouse’s cage (Chow, n=8; HFL, n=13). HFL mice gained more weight per gram of food
consumed than chow mice. Results represent mean ± SEM. *p<.0001
18

At sacrifice visceral adipose tissue was harvested and weighed. HFL mice exhibited increased
fat in the mesentery (data not shown) and a significant increase visceral adipose as seen in Figure
4.
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Figure 4. Total adipose tissue weight. Visceral adipose tissue was weighted at sacrifice.
Adipose tissue was greater in HFL mice compared to chow (Chow, n=12; HFL n=13). Results
represent mean ± SEM *p<.0001
In addition to increase in total fat content, adipocytes were also enlarged compared to chow mice
(Figures 5a and b). This is consistent with previous data showing that excess energy causes
adipocyte hypertrophy (Bays et al.).
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Chow

HFL

Figure 5a. Adipocyte Area. Representative images of visceral adipose tissue H&E stained
section demonstrate the hypertrophy that occurs with HFL feeding. (10X magnification)

P<.0001
*

Figure 5b. Adipocyte area. Random images of adipose histology were selected for adipocyte
size analysis. The area of 15-20 adipocyte per slide per mouse were determined. Adipocyte size
was larger for HFL mice than chow (Chow, n=7; HFL, n=9). Results represent mean ± SEM
*p<.0001
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Dysfunctional carbohydrate metabolism as demonstrated by insulin resistance and
glucose intolerance is a hallmark of diet-induced obesity. Fasting glucose levels were determined
and a glucose tolerance test performed. There was no difference in fasting blood glucose (data
not shown), but mice consuming a HFL diet showed a dramatic decrease in glucose clearance at
both 8 and 20 weeks, but the difference between groups was only significant when measured at
20 weeks (Figure 6).

Week 8

Week 20

*

HFL
Chow

Time (Minutes)

Figure 6. Glucose tolerance test over time. Blood glucose concentration was measured over a
90 minute period after IP injection with 2 g glucose/kg body weight at 8 (Chow, n=4; HFL, n=5)
and 20 weeks of age (Chow, n=4; HFL, n=7). HFL mice (red lines) showed worse glucose
tolerance response than chow mice (black lines). Results represent mean ± SEM *significantly
different at each time point, p<.05
Non alcoholic fatty liver disease is associated with a high fat diet. Even though there was
no difference in liver weight between the two diets (Figure 7a), there was a dramatic increase in
fat deposition liver exposed to HFL (Figure 7b), indicative of liver steatosis.
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Figure 7a. Liver health. Livers were harvested and weighed at sacrifice. HFL mice showed a
greater range of liver weights than chow mice (Chow, n=12; HFL, n=13). Results represent mean
± SEM

Chow

HFL

Figure 7b. Liver Health. Representative image of H&E stained liver section. HFL mice exhibit
a dramatic increase in fatty deposits in the liver seen as round white openings (indicated by black
arrows).
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A diet rich in ω-6 fatty acids alters circulating leptin but not cytokine levels
The adipokine leptin is secreted by the adipose tissue and has been shown to be
systemically increased during obesity. Circulating plasma leptin levels were higher in HFL mice
and increased over time (Figure 8) It is also known that hypertrophied adipose tissue releases
inflammatory cytokines, but we did not detect increased levels of TNFα, IL-6 or IL-1β in tissue
lysates or in the blood (data not shown).

*

Figure 8. Circulating plasma leptin over time. Plasma samples were obtained at 8 (Chow,
n=2; HFL, n=5), 16 (Chow, n=3; HFL, n=5), and on the day of sacrifice at 20 weeks of age
(Chow, n=3; HFL, n=5). HFL mice showed increased leptin over time, whereas chow mice
showed little detectable circulating plasma leptin. Results represent mean ± SEM *week 20
comparison between HFL and Chow, p=0.036.
Normal Estrous Cyclicity is altered in mice fed a high-fat diet rich in ω-6 fatty acids
Cycling was followed by vaginal lavage. Mice fed a chow diet demonstated a normal 4-5
day cycle as seen in Fig 9a. Mice fed a high-fat diet exhibited significantly longer estrous cycles
than their chow-fed counterparts (Figures 9a and 9b). HFL mice also showed a shortened
proestrus phase and a slightly lengthened estrus phase compared to chow mice (Figure 9c).

23

Chow
HFL
Figure 9a. Estrous Cyclycity. Five consecutive days of observation reveal normal 4-5 day cycle length in chow mice and
elongated cycle and altered vaginal cytology in HFL mice
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Figure 9b. Estrous Cyclycity. HFL mice exhibited longer cycles than chow mice over the
course of cycle monitoring (Chow, n=4; HFL, n=8). Results represent mean ± SEM *p=.0182

Figure 9c. Estrous Cyclycity. Phase length was normalized to cycle length and number of days
observed. HFL mice exhibited shortened proestrus phase but this difference was not significant.
There were no differences in any other phases (Chow, n=4; HFL, n=5). Results represent mean ±
SEM *trending toward significance, p=.069
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Intervention with an isocaloric diet containing fish oil diet rich in ω-3 polyunsaturated fatty
acids rescues metabolic outcomes and liver damage
Mice that were switched from the lard-based to the isocaloric fish oil based diet after 16
weeks of age showed reduced weight gain compared to mice that remained on HFL (Figure 10).
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Figure 10. Intervention total body weight gain. Total body weight was measured weekly from
weaning until 24 weeks of age for mice fed either HFL or switched to HFO after 16 weeks of age
(HFL, n=5; HFO Switch, n=7). HFL mice gained more weight over time than HFO mice. Results
represent mean ± SEM *significantly different at each timepoint; p<.05

During the intervention (week 16 -24), the mice consuming the HFO gained less weight/kcal of
food as compared to the mice consuming the HFL diet. The HFO mice did consume slightly but
not significantly less food (data not shown). This is consistent with data showing that a fish oil
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based diet induces an increase in the expression of transcription driving the fatty acid oxidation
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program as compared to fatty acid synthesis when consuming the HFL diet (Figures 10 and 11).

Figure 11. Weight gained per kcal of food consumed after intervention. Weight gained
during the intervention was normalized to the amount of energy consumed during this
timeperiod. (HFL, n=5; HFO Switch, n=7). HFL mice gained more weight per kcal of food
consumed than HFO mice. Results represent mean ± SEM *p=.048
The weight of visceral adipose tissue was significantly lower in mice switched to HFO
(Figure 12a). Despite the differences in adipose weight, adipocyte size was comparable between
the two groups (Figures 12b and c). To determine changes in carbohydrate metabolism, glucose
tolerance tests were performed at the beginning of intervention and at the end. At week 24 (end
of intervention) there was improvement in glucose tolerance (Figure 13a) and fasting insulin
levels (Figure 13b) for mice on the HFO diet. There was no difference observed in liver weights
between the two groups (Figure 14a), but a dramatic improvement could be seen in fat deposition
of mice switched to HFO (Figure 14b).
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Figure 12a. Intervention adiposity. Intervention adipose tissue weight shown as fraction of
total body weight. Visceral adipose tissue was weighted at sacrifice. Adipose tissue comprised a
greater fraction of total body weight in HFL compared to HFO (HFL, n=5; HFL n=7). Results
represent mean ± SEM

HFO
Switch

HFL

Figure 12b. Intervention adiposity. Representative histology of HFL and HFO Switch mice.
Adipocyte size did not differ between HFL and HFO mice.
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Figure 12c. Intervention adiposity. Random images of adipose histology were selected for
adipocyte size analysis. Adipocyte size comparable between the two groups (HFL, n=3; HFO
Switch, n=3). Results represent mean ± SEM
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Figure 13a. Intervention glucose tolerance test over time. Blood glucose concentration was
measured over a 90 minute period after IP injection with 2 g glucose/kg body weight prior to
intervention at 16 weeks (HFL, n=11), and prior to sacrifice at 24 weeks (HFL, n=5; HFO
Switch, n=7). HFO mice showed improved glucose tolerance compared to HFL
mice. Chow mice shown for reference (n=4).
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Figure 13b. Intervention fasting serum insulin before and after intervention. Fasting serum
sampled were collected prior to intervention at 16 weeks of age (HFL, n=3) and prior to sacrifice
at 24 weeks of age (HFL, n=2; HFO Switch, n=2). HFO mice showed lower fasting serum
insulin levels than HFL mice. Results represent mean ± SEM
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Figure 14a. Intervention liver health. Livers were harvested and weighed at sacrifice. There
was no difference in mean liver weights, but HFL mice showed a greater range of liver weights
than HFO mice (HFL, n=5; HFL, n=7). Results represent mean ± SEM
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HFL

HFO Switch

Figure 14b. Intervention liver health. Representative images of liver sections stained with
H&E after intervention. HFL mice exhibit fatty deposits (white holes) in the liver (indicated by
black arrows) while very few deposits could be detected in the mice consuming the HFO diet.
Intervention with fish oil diet alters leptin but not cytokine levels
Circulating plasma and adipose leptin levels were reduced in HFO mice compared to
HFL (Figures 15a and b). There were no detectable differences in adipose, liver, or circulating
plasma cytokine levels (data not shown).
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Figure 15a. Circulating plasma leptin levels after intervention. Plasma samples were
obtained on the day of sacrifice at 24 weeks of age. Leptin concentration were determined using
a multiplex bead assay, HFO mice showed lower plasma leptin levels than HFL mice (HFL, n=4;
HFO Switch, n=6). Results represent mean ± SEM

Figure 15b. Adipose tissue leptin levels after intervention. Adipose tissue leptin determined
from lysates of adipose tissue samples collected at sacrifice. Leptin concentration was
determined using a multiplex bead assay. HFO mice showed lower adipose leptin levels than
HFL mice (HFL, n=3; HFO Switch, n=4). Results represent mean ± SEM
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Intervention with fish oil diet somewhat alters immune populations
There were slight alterations in immune populations of interest in adipose tissue with fish
oil treatment (Figure 16). CD11b+ cells were reduced in fish oil intervention mice compared to
HFL mice, as were F4/80+ cells. Changes in T regulatory cell populations could not be

SS

SS

determined due to the lack of CD3+ cells in the sample (data not shown).

CD11

+

F4/80 (gated on CD11b

Figure 16. Intervention changes in adipose immune populations. Intervention mice exhibited
reduced percentage of A) CD11b+ cells and B) F4/80+ cells as compared to HFL mice.
Intervention with fish oil diet alters estrous cyclicity
At the end of intervention the mice could be classified as being high weight (greater than
30 g total body weight) or reduced weight (less than 30 grams total body weight) groups. The
high weight group did not have any alteration in the cycle length, while the reduced weight
group exhibited shorter cycles compared to mice that remained on HFL (Figure 17a). More
similar to what is seen when mice consume a show diet. HFL mice spent less time in proestrus
and longer in estrus compared to reduced weight mice switched to HFO (Figure 17b).
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*

Figure 17a. Intervention estrous cyclicity. HFL mice exhibited longer cycles than reduced
weight (total body weight less than 30 grams) HFO mice over the course of cycle monitoring
(HFL, n=7; HFO Switch, n=6). Results represent mean ± SEM *trending toward significance,
p=.069.

Figure 17b. Intervention cyclicity. Phase length was normalized to cycle length and number of
days observed. HFL mice exhibited shortened proestrus phase and lengthened estrus phase
compared to HFO mice (HFL, n=7; HFO Switch, n=9). Results represent mean ± SEM.
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Discussion, Conclusions, and Recommendations
Discussion
The relationship between metabolic dysfunction and infertility, particularly in the case of
PCOS, has long been known. Metabolic dysfunction has many manifestations, including obesity
with a high deposition of visceral fat and the development of insulin resistance. Interestingly,
many females diagnosed with PCOS have also been diagnosed with type II diabetes.
It is now well established that hypertrophic adipose tissue leads to low grade chronic
inflammation and that it is the release of these pro-inflammatory molecules that are driving many
of the pathologies associated with obesity, including type-II diabetes and cardiovascular disease.
The question therefore remains as to what affect a diet high in anti-inflammatory molecules, such
as contained in fish oil (omega 3 fatty acids) will have on the reproductive dysfunction
associated with obesity.
Few studies have been conducted to date on the effects of dietary supplementation with
omega-3 PUFAs and reproductive outcomes. Most studies focused on long term consumption
and not on the use of omega-3 PUFAs as an intervention at therapeutic levels. Nehra et al. saw
that a life-long consumption of a diet high in omega-3 PUFAs compared to omega-6 PUFAs (ω6:ω-3 ratio of 1:20 and 10% kilocalories from fat) elongated the reproductive lifespan of female
C57Bl/6 mice, and short term treatment near the age-related decline in murine reproductive life
with omega-3 PUFAs improved oocyte quality compared to omega-6 treatment, which in fact
reduced oocyte quality. Wakefield et al. fed female C57/Bl6 mice a diet high in omega-3 PUFAs
(ω-6:ω-3 ratio of 1:5.14 and 7% kilocalories from fat) compared to a chow diet and found
adverse effects in not only the maturing oocyte in the form of reactive oxygen species but also in
the morphological appearance and developmental ability of the embryo at the blastocyst stage.
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An earlier study in female rats showed increased ovulation with a low fat diet rich in ω-3
PUFAs, (10% fat and ω-6:ω-3 ratios of 1:0.2 and 1:1 for their low ω-3 and high ω-3,
respectively), (Trujillo and Broughton).
Based on this information, we hypothesized that a high fat diet (containing mostly ω-6
PUFAs) would generate a pro-inflammatory milieu, such that it would drive the development of
metabolic and reproductive dysfunction and that these dysfunctions could be rescued by a diet
rich in ω-3 PUFAs from fish oil possibly through its anti-inflammatory action.
We induced obesity, metabolic dysfunction, and cycle irregularity by feeding C57Bl/6
female mice a Western-type high-fat diet containing 45% fat from lard. Mice on this high-fat diet
gained 50.8% more total body weight than mice on a standard chow diet and demonstrated fatty
liver development and glucose intolerance from week 16 onwards. These female mice exhibited
a trend toward a shortened proestrus phase in agreement with previous diet-induced obesity
studies in C57Bl/6 mice (Sharma et al.).
To determine if the increase in weight has generated an increase in pro-inflammatory
cytokine secretion, we used a bead-based multiplex assay to determine protein levels. Low levels
of pro-inflammatory cytokines were detected in tissue lysates and plasma, but there were no
observable differences between the lard-based or fish oil intervention diet. However, there were
dramatic increases in leptin levels systemically and in the adipose tissue lysates for mice
consuming the high fat lard diet, with a decrease when consuming the fish oil diet. Systemic
leptin levels correlated with the amount of visceral adipose tissue. In addition to sending satiety
signals, leptin also promote the production of pro-inflammatory cytokines and phagocytosis
(Loffreda et al.), suggesting that the physiological environment created by the omega-6 fatty
acids from the lard diet, is in a pro-inflammatory state. In addition to increased leptin levels,
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glucose tolerance also deteriorated over time when consuming the lard diet. Glucose intolerance
results from attenuation of signaling through the insulin receptor. It is well-established that proinflammatory molecules such as TNF-α and Il-6 can alter the insulin signaling culminating in
insulin resistance. As various immune populations play a role in the increase of proinflammatory molecules, immune cells in the adipose tissue were phenotyped. There were no
differences in the T cells compartments, including Foxp3+ regulatory T cells in the visceral
adipose tissue. Although not significant, there was an observable reduction in infiltrating
CD11b+F4/80+ macrophages (these cells are associated with generating a pro-inflammatory
environment) when consuming the fish oil diet. Even though the differences in cell numbers
were small, there might be alterations in the functionality of these cells in regards to their
activating or suppressor capacity. As the fish oil diet was able to stop the exacerbation of glucose
intolerance, it suggests that the anti-inflammatory activity of this diet, especially induced by EPA
and DHA, reduces the inflammatory milieu, returning metabolic functionality and improve lipid
metabolism as suggested by Kopecky et al.
In addition to cytokines, sex hormones can also alter the inflammatory state, sex hormone
binding globulin (SHBG) is responsible for regulating the biological action of sex hormones and
binds with higher affinity to testosterone than to estradiol (Anderson). Insulin sensitivity has
been shown to be positively correlated with the production of SHGB, as insulin inhibits the
synthesis of SHBG in the liver (Lee et al.). Previous studies have shown that circulating SHBG is
reduced in individuals with greater amounts total body, visceral, and liver fat (Peter et al.).
Reduced circulating SHBG can result in increased circulating free testosterone, which is
implicated in the pathogenesis of both PCOS and type II diabetes mellitus (Le et al.; Dunaif). We
saw reduced visceral adiposity and liver fat deposition in conjunction with improved insulin
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sensitivity in fish oil intervention mice. Although not measured, it is possible that improved liver
SHBG synthesis in fish oil intervention mice influenced the improvement seen in estrous
cyclicity. Because we also saw improvement in hepatic steatosis in our histological analyses for
all intervention mice, it is unlikely that improvement in SHBG levels is the only factor in
improving reproductive cyclicity.
Metformin has served as a therapy for both women with PCOS presenting with infertility
as well as those with type II diabetes mellitus. Current dogma for PCOS asserts that insulin
resistance plays a major role in the pathogenesis and maintenance of PCOS, and it has long been
thought that metformin can improve fertility through its insulin sensitizing effects (Misso and
Teede). Metformin inhibits gluconeogenesis in the liver and improves insulin inhibition of
endogenous glucose production. Furthermore, metformin has been shown to reduce hepatic
steatosis and lipogenesis while increasing fatty acid oxidation (Foretz et al.). We saw a reduction
in hepatic steatosis, fasting insulin, and lipogenesis in fish oil intervention mice, suggesting a
diet containing large amounts of ω-3 fatty acids can provide many of the same benefits as
metformin, including improving the insulin sensitivity that may influence reproductive
dysfunction. It is worth noting that more recently, however, the efficacy of metformin in the
treatment of infertility related to PCOS has been disputed, as both lifestyle changes and other
pharmacological interventions have been shown to be more effective than metformin alone (Abu
Hashim).
Conclusions
We conclude that diet-induced obesity and obesity-related reproductive dysfunction can
be established through feeding a Western-type diet containing 45% kcal fat from with a high
amount of ω-6 PUFAs. Although we saw overall improvement in metabolic and reproductive
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outcomes, considerable variability of response to fish oil intervention treatment in terms of
individual metabolic outcomes and estrous cyclicity was observed (Table 3), and there was no
discernible relationship between one specific metabolic outcome or all metabolic outcomes taken
together and estrous cycle regularity. From this we can conclude that intervention with a fish oil
diet rich in ω-3 versus ω-6 PUFAs can rescue diet-induced obesity and estrous cycle
irregularities in females, but not all individuals may be responsive to this treatment to the same
degree.
Table 3. Variability in individual response to fish oil treatment. Individual metabolic and
reproductive outcomes varied amongst the fish oil mice. Means for chow and lard mice at 24
weeks of age are shown for reference.
Mouse ID

Final Weight

90’ GTT blood glucose

Cycle Length

Proestrus Length

2.002

29.4

230

5

1

2.004

34.53

NA

10

3.5

2.005

29.79

600

6

0.6

2.007

39.41

259

4

0.85

2.009

27.4

228

5

1

2.010

29.04

NA

6

1.36

2.017

26.89

421

5

1.43

2.019

29.22

460

5

0.7

Chow (mean)

23.88

265

4-5

1.23

Lard (mean)

40.176

492.8

7.07

1.34

Recommendations
A larger intervention group and subsequent multivariate statistical analysis may help to elucidate
relationships between specific metabolic outcomes and estrous cyclicity such that a more focused
approach toward specific biomolecular pathways can be taken. Additionally, future studies
should be conducted altering the ω-3:ω-6 fatty acid ratio to find the most clinically relevant and
effective dietary intervention with ω-3 PUFAs.
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IACUC Approval
IACUC PROTOCOL
FOR USE OF LIVE VERTEBRATES FOR RESEARCH, TEACHING OR DEMONSTRATION

UNIVERSITY OF MEMPHIS
IACUC Protocol # 0761

1/27/15

Date Submitted to IACUC

Dates Protocol will be in effect:
from
(not to exceed three years including two yearly renewals)

3/3/15

to

Is this protocol related to an external grant or contract application?

3/2/17

Yes

No X

If yes, complete the following:
Agency:

Date Submitted

Grant #
University account for Animal Care Facility per diem charge:
If the protocol is not related to an external grant or contract application, complete the following:
University account for Animal Care Facility per diem charge:

211700

Project Title: (If project relates to a grant or contract application, give that title; if the project is related to
a class, give the course name and number):
High-fat diet induced inflammation and reproductive dysfunction in mice
I.

Personnel

Investigator/Instructor:

Marie van der Merwe

Department:

Health and Sport Sciences

Academic Rank:

Assistant Professor

Campus phone:

901 678 3476

Attending Veterinarian:
Phone:

Emergency phone:

901 406 7458

Karyl Buddington

901 678 2359

Emergency phone:

901 258 1232

List all individuals that will handle animals using this protocol and their level of expertise (e.g. relevant
qualifications). If the protocol applies to a class then so specify.
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Marie van der Merwe – PhD (Molecular Pharmacology), Postdoctoral Fellowship (Bone Marrow
Transplantation): More than 10 years of experience using mice as a research model.
Simone Godwin – BA (Anthropology), Animal husbandry internship at Duke Lemur Center (Durham),
Primate conservation and rehabilitation internship at Alouatta Sanctuary (Panama), Research assistant for
Buddington Lab (Memphis)
LeeAnna Beech – B.S (Dietetics), A.S (Science), Animal trainer certification at Dolphin Quest (O’ahu)
If additional personnel become involved in handling animals used in this protocol, it is the
responsibility of the principal investigator to notify the Animal Care Facility in writing before they
start.
If applicable, has the investigator/instructor and all personnel listed above
received the appropriate vaccinations (tetanus, rabies)?
Yes X
Is it necessary for personnel listed on this protocol to be tested for TB?

Yes

No
No X

If you have questions about the kind of vaccination or about TB, call the Animal Care Facility at
678 2034.
All U of M personnel involved in this protocol must complete the animal care and use training
program (satisfactory completion of, or concurrent registration in Biol 7006/8006), or have
completed a comparable training program at another institution before animals can be procured or
before the experiments/teaching or demonstration. In submitting this protocol, I, as Principal
Investigator/Instructor accept the responsibility for compliance with this requirement.
In addition, the Principal Investigator/Instructor must be willing to provide appropriate
supervision for all persons working on this protocol. In the case of a class, the Instructor must be
responsible for training any students in classes involved prior to using animals.
II.

Project Description

A.

Summary (Enter a brief description below of your project, using lay terminology):
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Energy status and reproductive status are closely related, as energy stores must be adequate to fuel
such energetically costly processes such as pregnancy, birth, and lactation. Obesity, which can be
considered chronic energy excess, and its associated metabolic conditions (chronic low-grade
inflammation, type II diabetes, glucose intolerance, dyslipidemia, increased adiposity, high blood pressure,
and high leptin and low adiponectin levels) has been shown to influence female reproductive function in
both humans and research animals, mainly by disrupting or ceasing cycling altogether. The aims of this
experiment are 1) to establish whether reproductive dysfunction (measured via estrous cycle regularity) can
be induced by a high-fat Western-type diet in C57Bl/6 mice, 2) determine if the source of fat has any
ability to protect or reverse this dysfunction and 3) determine the relationship between cycle regularity and
inflammatory status over time.
We will use a mouse model (C57BL/6) that will receive either a 45% fat (lard) diet, typical of a “Western”
diet, or a 45% fish oil diet which is high in omega-3 fatty acids. Control mice will be on a “normal” 10%
fat diet. Omega-3 fatty acids have previously been shown to reduce inflammation and decrease risk of
development of glucose intolerance.
After weaning, mice will be exposed to one of the aforementioned diets, and vaginal smears will be
conducted daily to assess estrous cycle phase. Eating habits (amount of food consumed) and weights of
mice will be monitored twice a week. Mice will be bled biweekly to look at adipokine and cytokine
changes that are associated with the different diets. Because inflammation and type 2 diabetes are highly
associated, mice will also undergo a glucose tolerance test on the same schedule. After mice on the high fat
lard diet begin to exhibit irregular cycles (approximately 12 weeks but not to exceed 16 weeks), they will
be euthanized, at which point the brain, ovaries, adrenal glands, liver, spleen, mesenteric lymph nodes and
adipose tissue will be harvested for analysis.
B.

Describe IN DETAIL the procedures you will follow. You may do this in either of two
ways (Check one of the options below and follow the associated instructions):

1.

Accompanying documentation (include documentation in box below).
OR

2.

By reference to previously published work (provide a complete bibliographic citation
in the box below, and describe any variations from the published technique).
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X

Mice: C57BL/6 female mice will be used for this study and obtained from breeder pairs purchased from
Harlan Labs and that are bred and housed at the animal facility on the University of Memphis campus.
Diets: All of the mice will be weaned at 3 weeks of age (which is the standard weaning time for C57BL/6
mice) onto the one of the following diets: 1) control (standard chow) diet, 2) western diet with 45% lard
and 41% carbohydrate (20% sucrose, 9% corn starch and 12% Maltodextrin 10), or 3) 45% fish-oil and
41% carbohydrate (20% sucrose, 9% corn starch and 12% Maltodextrin 10). For aims 1 and 2 the mice will
remain on their respective diets throughout the test period. To determine if the fish oil diet can reverse the
irregular cycling, the lard-based diet group will be switched to the fish-oil diet at the onset of irregular
cycles. The diets will be purchased from Research Diets, which has experience in producing the western
diet for rodent studies.
Experimental design:
For aim 1, 18 female mice will be divided into 3 groups. At weaning, group 1 will receive the lard diet,
group 2 the fish oil diet, and group 3 the control diet (8 mice/group). Once mice reach puberty (determined
by vaginal opening), vaginal smears will be conducted daily to assess estrous cycle phase. Blood samples
will be collected from all mice biweekly via the facial vein to determine alterations in adipokines,
cytokines and regulatory immune populations such as Regulatory T cells and Myeloid Derived Suppressor
cells. Mice will be anesthetized with isoflurane (2-4%) via inhalation for less than 10 minutes during facial
vein blood collections (Collecting 100-200ul of blood). The glucose tolerance test will also be performed
biweekly (on a different day as blood collection), by fasting the mice for 6 hours and then administering
glucose at1g glucose/kg body weight intraperitoneally. 10-20 ul of blood will be collected via the tail vein
at 30 minute intervals for 90 minutes to measure glucose levels. No anesthetic will be used for tail vein
blood sampling as it alters the systemic glucose levels, but mice will be held in hand and the tail gently
“milked”. Before this procedure the mice will be held often to get them used to being handled. Once
cyclicity becomes consistently irregular in the lard diet group (or at 16 weeks, whichever comes first), all
mice will be euthanized (CO2 inhalation) to harvest the brain, ovaries, adrenal glands, liver, spleen,
mesenteric lymph nodes, intestines and adipose tissue for histology, biochemistry and immune cells
harvest.
For aim 2, female mice will be divided into 2 groups: one group (n=8) will receive the control diet and the
second group (n=12) will receive the high fat lard diet. Once cycle irregularity has been established (~12
weeks), the high fat lard diet group will be transferred to the fish oil diet and followed for an additional 6
weeks. Vaginal smears will be conducted to establish whether the fish oil intervention can rescue diet
induced reproductive dysfunction. For this group, blood samples collected via the facial vein will be done
on the second day of diestrus phase of each cycle to control for hormonal variation. The glucose tolerance
test will be performed biweekly on the second day of diestrus. At the end of intervention and second day of
diestrus (~18 weeks), all mice will be euthanized to harvest brain, ovaries, adrenal glands, liver, spleen,
mesenteric lymph nodes and adipose tissue for histology, biochemistry and immune cells harvest.
For aim 3, we would like to establish a timeline for the onset of reproductive disturbances, metabolic
syndrome, and inflammatory status in various organs. Blood parameters would have been already
determined in aim 1, therefore this aim will focus on changes on tissues. For this experiment, 8 female
mice will be placed on the chow diet, 6 on high fat lard diet, and 6 on the fish oil diet at weaning for 12
weeks. Half of each group will be euthanized early, 6-8 weeks of age (depending on when irregular cycles
start as determined in Aim 1 ) to examine any early changes in the metabolic and reproductive phenotype.
The other half will continue until 12-14 weeks (timepoint when irregularity is often seen), at which point
they will be euthanized to harvest brain, ovaries, adrenal glands, liver, spleen, mesenteric lymph nodes,
intestines and adipose tissue for histology, biochemistry and immune cells harvest.
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C.

Rationale for Involving Animals and the Appropriateness of Species and Number Used.

Indicate (here) briefly the short and/or long-term benefits (to humans and/or other animals) of this use of
animals for research, teaching or demonstration. In addition, state briefly why living animals are required
for this study, rather than some alternative model.
The goal of this experiment is to mimic the metabolic syndrome and associated reproductive complications
characteristic of obese humans. The cause of this obesity-induced reproductive dysfunction has yet to be
fully elucidated, but degree of obesity have been highly correlated with degree of cycle irregularity. Given
that chronic low-grade inflammation is characteristic of diet-induced obesity, we hope to establish a link
between inflammatory status and reproductive dysfunction. We are interested in the kinetics of the onset of
metabolic syndrome and reproductive dysfunction and also what role the immune system plays in setting
up the environment for the disorder and estrus irregularities.
The C57BL/6 diet induced obesity (DIO) mouse model has been used previously to look at the effect of
excess weight on various organ systems. As we are interested in the interaction between the immune
system what role it plays in the onset of metabolic phenotype and estrous cycle irregularities in mammals,
we thus cannot use isolated cell lines or model organisms such as yeast. Many previous studies have used
obese rodent models to examine the downstream effects of metabolic syndrome on reproductive function.
Additionally, many reagents have been developed for the use of mouse tissues, especially antibodies that
will be used to identify immune populations.
There will be 6-10 mice per group for each experiment (2-3 groups/experiment) and 3 experiments. This
number should be sufficient to determine statistical significance and account for any unanticipated issues
that may arise.
D.

Do the procedures described in B above, have the potential to inflict more
than momentary pain or distress (this does not include pain caused by
injections or other minor procedures)?
Yes

No X

If yes, please address the following:
I have considered alternatives to procedures that might cause more than momentary or slight pain/distress,
and I have not found such alternatives. As such, I have used one or more of the following methods and
sources to search for such alternatives: (check below each method used)
Agricola Data Base
Medline Data Base
CAB Abstracts
TOXLINE
BIOSIS
Lab. Animal Sci. Journal
Lab. Animals Journal
Lab Animal
Animal Welfare Info Center
ATLA (Alternatives to Laboratory Animal Journal)
Quick Biblio. Series
Lab Animal Welfare Bibliography (QL55L27311988)
"Benchmarks"
"Alternatives to Animal Use in Research, Testing and Education"
Current Contents
CARL
Direct contact with colleagues (if selected, you MUST document this below)
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List search words for the literature search:
Reproduction and metabolism, diet induced obesity, inflammation, estrous cycle, C57Bl/6, reproductive
dysfunction, inflammation
What is the length of time that the literature search covers? 1983 - present

III.

Animal Use

A.

List all animal species to be used (example below).

Species

Number1

Age2

90

21 days

C57BL/6 mice

Sex2

Weight2

Female

20-25 gm

Where Housed
(Bldg./Rm#)
Psychology Bld./422I

1

Individuals using ectotherms need to only approximate numbers.
Individuals using fish or other ectotherms need not answer this question.

2

Is any species threatened or endangered?
B.

Yes

No X

Source of animals

X Commercial vendor (Source: Harlan Labs) Female mice and male mice will be purchased for breeding
X Bred at The University of Memphis
Captured from wild
Transferred from another study (IACUC Protocol Number
)
Donated (Source
)
Tennessee Wildlife Resources Agency
Purchased and supplied by TMGC
Is the supplier a USDA approved source?
Yes X
No
If not, explain why:
Animals are already in residence at U of M
C.

Will surgery be conducted on animals?

Yes

If yes, complete this section:
Non Recovery Surgery

Recovery Surgery
50

No X

Multiple Survival Surgery (if the latter is checked, complete section F)
Surgeon(s) (Name/Job/Title/Academic Rank)

D.

Location of Surgery (Bldg. & Room #)

Will Anesthetic(s), Analgesic(s), or
Tranquilizing agents be administered?

Yes X

No

If yes, complete this section (example below).
Species & Sex

C57BL/6 mice

Agent

Isoflurane

Dose

2-4%

Route

Inhalation

E.
Will euthanasia be carried out?
If yes, complete this section (example below).
Species & Sex

C57BL/6 mice

Agent

CO2

Performed by
(Name/Title/Academic Rank)
Marie van der Merwe/ Assistant
Professor
Simone Godwin/Masters Student
LeeAnnaBeech/Masters Student

Yes X

Dose

3L/min

Route

Inhalation

No

Performed by
(Name/Title/Academic Rank)
Marie van der Merwe/ Assistant
Professor
Simone Godwin/Masters Student
LeeAnnaBeech/Masters Student

If no, describe disposition of animal(s) at conclusion of this study in box below.

F.

Will special housing, conditioning, diets or other conditions
be required?

If yes, please explain in box below.
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Yes X

No

Mice will be on special high fat (either lard/fish oil) diets acquired from Research diets. The diets must be
refrigerated or frozen.

G.

Will animals be removed from the U of M campus at any time?

Yes

No X

If yes, please indicate to where and for how long in box below.

H. If they are to be housed for more than 24 hours outside approved facilities at U of M, provide a
scientific justification in box below.

IV.

Toxic and Hazardous Substances

A.

Check off any of the following below that will be used in these experiments?
Infectious agents (Fill out a, b)
Radioisotopes (Fill out a, b, e)
Toxic chemicals or carcinogens (Fill out a, b)
Recombinant DNA (Fill out a)
Experimental drugs (Fill out a)
Malignant cells or hybridomas (Fill out a, c)
Adjuvants (Fill out a)
Controlled substances (Fill out a, d, e)

For each checked off category, answer the questions indicated below:
a.

Identify the substance(s) and completely describe their use, including how will be injected or given
to the animal(s):

b.

Describe all procedures necessary for personnel and animal safety including
waste, carcass disposal and cage decontamination:

c.

If transplantable tumors or hybridoma cells are to be injected into the
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biohazardous

animals, have the tissues/cells been tested for inadvertent contamination
by viruses or mycoplasma?
Yes

No

If yes, what was the result (indicate in box below).

d.

In the box below, provide a complete list of these substances, and if their use is not explicitly
explained in the materials already provided, explain their use and role in the research.

Provide DEA license # covering the use of these substances:
To whom (or what entity) is the license issued?
e. Provide Radioisotope License Number:
To whom is the license issued?
V.

Categories of Animal Experimentation Based Upon Level of Manipulation and Pain:
(check off each category that is applicable to this application)

X

A.

Animals will be involved in teaching, research, experiments or tests involving
distress, or use of pain-relieving drugs.

X

B.

Animals will be subject to mild stress only (e.g., food or water deprivation of less than 24
hours for use in behavioral studies such as operant conditioning; physical restraint for less
than 30 minutes), and will not be subject to surgery, painful stimuli, or any of the other
conditions described below. Procedures described in this protocol have the potential to inflict
no more than momentary or slight pain or distress on the animal(s)----that is, no pain in
excess of that caused by injections or other minor procedures such as blood sampling.

X

C.

Animals will have minor procedures performed, blood sampling, etc. while anesthetized.

X

D.

Live animals will be humanely killed without any treatments, manipulations, etc. but will be
used to obtain tissue, cells, sera, etc.

E.

Live animals will have significant manipulations, surgery, etc. performed while anesthetized.
The animals will be humanely killed at experiment termination without regaining
consciousness.

F.

Live animals will receive a painful stimulus of short duration without anesthesia (behavior
experiments with flight or avoidance reactions--e.g., shock/reward) resulting in a short-term
traumatic response. Other examples in this category are, blood sampling, injections of
adjuvants, or drugs, etc.
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no pain,

VI.

G.

Live animals will have significant manipulations performed, such as surgery, while
anesthetized and allowed to recover. Such procedures cause post-anesthetic pain/discomfort
resulting from the experiment protocol (e.g., chronic catheters. surgical wounds, implants)
which cause a minimum of pain and/or distress. Also included are mild toxic drugs or
chemicals, tumor implants (including hybridomas). tethered animals, short-termed physically
restrained animals (up to 1 hour), mother/infant separations.

H.

Live animals will have significant manipulations or severe discomfort, etc. without benefit of
anesthesia, analgesics or tranquilizers. Examples to be included in this category are: toxicity
testing, radiation sickness, irritants, burns, trauma, biologic toxins, virulence challenge,
prolonged: restrictions of food or water intake, cold exposure, physical restraint or drug
addiction. All use of paralytic agents (curare-like drugs) must be included in this category.
Describe any abnormal environmental conditions that may be imposed. Describe and justify
the use of any physical restrain devices employed longer then 1 hour.

Justifications for Category G Studies and Deviations from Standard Techniques

Describe in the box below any steps to be taken to monitor potential or overt pain and/or distress during
the course of this study and how such pain or distress will be alleviated. Be as detailed as necessary to
justify your procedure.

VII. Certifications
(By submitting this protocol, I am acknowledging that I comply with the certifications
included in Section VII.) (check one)
X

Animal Use for Research. I certify that the above statements are true and the protocol stands as the
original or is essentially the same as found in the grant application or program/project. The IACUC
will be notified of any changes in the proposed project, or personnel, relative to this application,
prior to proceeding with any animal experimentation. I will not purchase animals nor proceed with
animal experimentation until approval by the IACUC is granted.

Animal Use for Teaching/Demonstration. I certify that the information in this application is
essentially the same as contained in the course outline and a copy of the laboratory exercises using
animals is on file in the IACUC office. The IACUC will be notified of any changes in the proposed
project, or personnel, relative to this application, prior to proceeding with any animal
experimentation. I will not proceed with animal experimentation until approval by the IACUC is
granted.

Estimate the cost of maintaining animals used in this protocol based on current per diem charge at
University of Memphis.
Please specify cost per unit of time:

$0.25/day/cage
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$ 1680

Specify anticipated total costs for project duration:
As supervisor of this project it is required that you inform your department chair concerning any
animal per diem costs related to this project that are to be paid by the department.
By submitting this protocol, the Principal Investigator/Course Director indicates that the following
have been considered:
1.
2.
3.
4.
5.
6.
7.

Alternatives to use of animals.
Reduction of pain and stress in animals to the lowest level possible.
The proper needs of the animals with respect to housing and care.
The lowest number of animals used that will give the appropriate experimental results.
Use of the most primitive species that will give the appropriate experimental results.
Proper training of all personnel in the care and handling of the species used and in the procedures
called for in this protocol before beginning the experiment/teaching or demonstration.
That this protocol is not an unnecessary repeat of results already in the literature or in the case of
teaching/demonstrations, results that can be demonstrated using models or video material.

Principal Investigator/Course Director (Type Name)
e-mail address
Date

Marie van der Merwe

mvndrmrw@memphis.edu

7/21/14

Federal Law requires that members of the IACUC be given adequate time to read and review protocols
including any changes or revisions in them.
The University of Memphis IACUC evaluates protocols on a continuous basis. Any protocols or
modifications or renewals to any protocols to be considered at this time must be received by the Animal
Care Facility no later than the end of the second week of the previous month.
Incomplete protocols will be returned to the principal investigator. We will not accept a FAXed protocol,
renewal form or changes to a protocol.
E-mail the completed protocol to Dr. Guy Mittleman (Dept. Psychology):
mailto:<g.mittleman@mail.psyc.memphis.edu>?subject=RE: IACUC Application
January, 2008
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